TOKYO -- Olympus will acquire South Korean stent maker Taewoong Medical for about $370 million in its second-biggest acquisition ever, the Japanese medical devices company said on Friday.
Deal marks major foray into new area for world's top endoscope maker

Olympus is looking to beef up its medical device offerings and find new revenue sources outside its core strength in optical equipment. (Source photos by Reuters and Taewoong Medical)
TOKYO -- Olympus will acquire South Korean stent maker Taewoong Medical for about $370 million in its second-biggest acquisition ever, the Japanese medical devices company said on Friday.